Advexin (Ad5CMV-p53) combined with docetaxel (T) and doxorubicin (D) as induction chemotherapy (IC): significant efficacy of a novel gene-therapy approach for patients with locally advanced breast cancer (LABC).

A Crislofanilli, S Krishnamurthy,L Guerra,B Arun,R Walters,DJ Booser, MC Green, SW Kau,K Menander, HJ Van Wart, V Valero,GN Hortobagyi

BREAST CANCER RESEARCH AND TREATMENT(2004)

引用 0|浏览7
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要